FDA outlines framework for adaptive AI-based medical devices

FDA is giving stakeholders a chance to weigh in on the agency’s proposed framework for regulating adaptive artificial intelligence- or machine learning (ML)-based software as a medical device (SaMD). The agency laid out

Read the full 334 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE